Skip to main content

Table 1 Origin and reference of bacterial strains used in the present study

From: Bacterial membrane activity of α-peptide/β-peptoid chimeras: Influence of amino acid composition and chain length on the activity against different bacterial strains

  Origin Ref
S. aureus 8325-4 Wildtype [59]
K. pneumoniae ATCC 13883 Human, clinical -
S. marcescens ATCC 8100 Human, clinical -
E. coli ATCC 25922 Wildtype -
E. coli MG1655 K-12 F- lambda- [60]
E. coli AAS-EC-009 Human, clinical a
E.coli AAS-EC-010 Human, clinical a
L. monocytogenes 4446 Human, clinical [61]
L. monocytogenes N53-1 Food processing [62]
L. monocytogenes EGD Wildtype b
V. vulnificus ATCCT Human, clinical -
V. parahaemolyticus ATCCT Human, clinical -
  1. Susceptibility testing were carried out with a selection of twelve different bacterial strains comprising common laboratory strains and clinical strains derived from food-borne pathogens as well as pathogens responsible for nosocomial infections. a ESBL-producing clinical samples from Danish patients in 2007; b This strain was kindly provided by Werner Goebel, University of Würzburg.